Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (
Gucci owner takes over Puma | Business | The Guardian
Frontiers | PUMAA: A Platform for Accessible Microbiome Analysis in the Undergraduate Classroom